Bayer supervisory board to meet to discuss crisis - report
Reuters
Published May 01, 2019 10:50
Bayer supervisory board to meet to discuss crisis - report
BERLIN (Reuters) - The supervisory board of Bayer (DE:BAYGN) is planning an extraordinary meeting to discuss a crisis of confidence in its leadership after an investor rebuke at the German drugmaker's annual meeting, a magazine reported on Wednesday.
Citing an unnamed board member, Wirtschaftswoche magazine said the meeting would take place in the next two or three weeks: "We can't just carry on like this," the person said.
A Bayer spokesman declined to comment.
At Bayer's annual shareholder meeting on Friday a majority of investors cast a vote of disapproval of top management's actions.
On Saturday, the supervisory board said in a statement that it unanimously stands behind the company's management, adding that it would continue to examine the results of the AGM in the weeks ahead.
On Monday, three of Bayer's largest German investors said the drugmaker's management needed to stay at the helm to avoid further upheaval, despite their unease over a share price slump in the wake of the company's $63 billion (£48 billion) takeover of Monsanto (NYSE:MON).
About 30 billion euros ($34 billion) have been wiped off Bayer's market value since August, when a U.S. jury found it liable because Monsanto had not warned of alleged cancer risks linked to its weedkiller Roundup. More than 13,000 plaintiffs are claiming damages.
Bayer is appealing or plans to appeal the Roundup verdicts and has pointed to global regulators' findings that the use of glyphosate, the active ingredient in the herbicide, is safe.
On Tuesday, the U.S. Environmental Protection Agency (EPA) said that glyphosate is not a carcinogen, contradicting decisions by U.S. juries that found it caused cancer in people.
Get The App
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.